Also trades as: 0HF9.L (LSE) · $vol 0M
FOLD NASDAQ
Amicus Therapeutics, Inc.
1W: +0.2%
1M: +0.4%
3M: +1.4%
YTD: +1.5%
1Y: +101.2%
3Y: +26.0%
5Y: +48.0%
$14.49
Last traded 2026-04-27 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$634M
Revenue
+20.0% YoY
$-27M
Net Income
+51.7% YoY
$30M
Free Cash Flow
+179.7% YoY
84.6%
Gross Margin
8.6%
Op. Margin
0.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-11.6%
ROA-3.1%
ROIC-1002.9%
Valuation
P/E-783.2
P/B16.3
EV/EBITDA86.7
Leverage
Debt/Equity1.76
Current Ratio2.84
Interest Cov.1.0x
Quality Scores
Piotroski F5/9
Altman Z1.28
Beneish M-2.64